InsidersTradesSigma
Track the CBL share price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Healthcare & Pharma sector, CBL has logged 5 insider filings. Market capitalisation: €28.5m. The latest transaction was disclosed on 3 July 2026 (Change in Substantial Holding). Among the most active insiders: Phoenix Development Fund Limited. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,137 of 28,896 companies
76.5
score / 100
Value81
Quality73
FCF yld14%
Earn yld7.8%
EV/EBITDA7.9x
ROE62%
Gross mgn65%
Net mgn23%
Debt/EBITDA4.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations5 total
ShareASXASX:2924-03107639-2A1682246
ShareASXASX:2924-03090203-2A1672120
ShareASXASX:2924-03090202-2A1672119
5 of 5 declarations
About CBL
CBL is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions to enhance healthcare.
